# A Study Evaluating the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection

> **NCT07710560** · PHASE1 · COMPLETED · sponsor: **Hunan Kelun Pharmaceutical Co., Ltd.** · enrollment: 27 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** KL0011034 injection
- **DRUG:** Alfentanil Hydrochloride Injection

## Key facts

- **NCT ID:** NCT07710560
- **Lead sponsor:** Hunan Kelun Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-07-15
- **Primary completion:** 2026-08-12
- **Final completion:** 2026-08-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2026-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07710560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07710560, "A Study Evaluating the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07710560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*